CRMD, CELC, RANI, and RAPT are pushing aggressively to the upside on Monday. Here's what is driving these four biotech stocks ...

Biotech stocks rebound after years of weakness as M&A, lower rates and easing policy fears draw investors back to the sector.

Leverage RWE strategically to build regulator-ready submissions.

Claude for Life Sciences is based on Anthropic’s most powerful large language model Claude Sonnet 4.5. It’s designed to ...

Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and ...

Acadia Pharmaceuticals CEO Catherine Owen Adams breaks down the company’s recent rebrand, its expansion into rare disease marketing and how it’s using AI.

Oncolytics Biotech (ONCY) has established a new at-the-market equity financing agreement with BTIG, LLC. As disclosed in a Securities and Exchange Commission ((SEC)) filing on October 17, 2025, the de ...

The biomedical research facility in South Jersey is expected to create about 150 new permanent jobs plus 100 construction ...

As Labiotech attented the NLS Days this week, it was the occasion to learn more about the biotech industry in Sweden.

The Pennsylvania Biotechnology Center of Bucks County is looking at developing a new laboratory and office building on a 2.85 ...

The total market capitalization of China’s publicly listed biotech firms has reached $1.5 trillion, second only to that of the United States. As China surges, many traditional American strengths have ...

Sheila Gujrathi, former CEO of Gossamer Bio, has written a new book that aims to offer the type of leadership manual she ...